Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access
NCT07141641
·
clinicaltrials.gov ↗
TEMPORARILY_NOT_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Vascular Diseases
End Stage Renal Disease on Dialysis
Interventions
BIOLOGICAL:
Acellular Tissue Engineered Vessel (ATEV)
Sponsor
Humacyte, Inc.